about
A clinical perspective of sepsis-associated deliriumStatin therapy for acute respiratory distress syndrome: an individual patient data meta-analysis of randomised clinical trials.Statins and delirium during critical illness: a multicenter, prospective cohort study.Association between statin use at admission to inpatient rehabilitation and functional status at discharge among older patients.Evaluating early administration of the hydroxymethylglutaryl-CoA reductase inhibitor simvastatin in the prevention and treatment of delirium in critically ill ventilated patients (MoDUS trial): study protocol for a randomized controlled trial.Rosuvastatin versus placebo for delirium in intensive care and subsequent cognitive impairment in patients with sepsis-associated acute respiratory distress syndrome: an ancillary study to a randomised controlled trial.Association of rosuvastatin and delirium in severe sepsis with acute respiratory distress syndromeStatins and delirium: is there a role?Update in Mechanical Ventilation, Sedation, and Outcomes 2014.Septic encephalopathy and septic encephalitis.Preventive strategies and potential therapeutic interventions for delirium in sepsis.Intensive Care Unit Delirium: A Review of Diagnosis, Prevention, and Treatment.Pharmacogenomics and pharmacogenetics for the intensive care unit: a narrative review.The intensive care delirium research agenda: a multinational, interprofessional perspective.Use of antipsychotics for the treatment of intensive care unit deliriumOf delirium and sedation.The 2014 updated version of the Confusion Assessment Method for the Intensive Care Unit compared to the 5th version of the Diagnostic and Statistical Manual of Mental Disorders and other current methods used by intensivists.
P2860
Q26751613-80133F6D-D3CD-44B4-B785-443AA6684831Q31150571-7B946CA7-8A3C-478C-818D-8EF98F1BBF20Q33921904-AA2EC825-45BD-4542-A56F-35A2C63849FFQ34729846-1A233B0B-FCB7-45B3-A795-43170BA2CECAQ35633655-A6CD2C9D-31D1-4256-907F-C1A8EC657575Q36689726-77A80CFA-54A5-4E04-B6A6-F673CFED80B9Q37208745-AA4E1C47-B770-49DC-B254-E2C9C38F6178Q38268343-0498D3E7-3E67-4191-88EB-64912DE58310Q38527919-870EA212-B469-4679-A791-9D486B597F50Q38790900-87784885-52EA-42AC-A33D-2AF1C5B88903Q38862634-61DDC5EE-5048-4212-8AF4-05083298B5C1Q38982498-50E005B4-ECDE-4A52-AE53-BCEE63B99946Q38983589-284414E5-3479-41FA-8AED-312CCEB8941AQ39371231-6F01F324-C8BC-40F9-8E78-C056E0238242Q42740056-CD69B5BD-CA53-498F-B8BF-66A4CF0085AAQ47899226-5915A675-1D01-4A03-A6A8-9F2218AFA5B8Q52680290-6D52233A-F43D-4D70-950E-6EF91A8A4105
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Statin use and risk of delirium in the critically ill.
@en
Statin use and risk of delirium in the critically ill.
@nl
type
label
Statin use and risk of delirium in the critically ill.
@en
Statin use and risk of delirium in the critically ill.
@nl
prefLabel
Statin use and risk of delirium in the critically ill.
@en
Statin use and risk of delirium in the critically ill.
@nl
P2093
P2860
P50
P1476
Statin use and risk of delirium in the critically ill
@en
P2093
Annalisa Casarin
E Wesley Ely
Thomas Brown
Valerie J Page
Xiao B Zhao
P2860
P304
P356
10.1164/RCCM.201306-1150OC
P407
P577
2014-03-01T00:00:00Z